Tag: aortic stenosis market report

  • Market Analysis on Aortic Stenosis Industry – Insights for Corporate Strategy and R&D

    Market Analysis on Aortic Stenosis Industry – Insights for Corporate Strategy and R&D

    Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

    What Is the Forecast for the Aortic Stenosis Market from 2024 to 2025?

    The market for aortic stenosis has experienced swift expansion in recent times. The market worth, currently pegged at $7.88 billion in 2024, is predicted to surge to $8.93 billion in 2025, with a compound annual growth rate (CAGR) of 13.3%. Various factors responsible for the growth observed in the past include an aging populace, enhanced occurrence of risk factors, technological advancements in diagnostics, increased cognizance of cardiac diseases, and the improvement of healthcare infrastructure.

    What Is the Projected Market Size of the Aortic Stenosis Market?

    In the coming years, the aortic stenosis market is slated for accelerated growth, with projections estimating it to reach $14.54 billion by 2029, reflecting a compound annual growth rate (CAGR) of 12.9%. The growth anticipated during the forecast period could be attributed to the increasing preference for minimally invasive procedures, the growing elderly population, the surge in healthcare expenditures, enhancements in aortic valve replacement technologies, and expanded access to healthcare in evolving markets. During the same period, significant trends are set to mainstream, including the adoption of robotic-assisted surgeries, 3D imaging and visualization, advancements in transcatheter aortic valve replacement (tavr), artificial intelligence applications in diagnostics, and the use of biodegradable stents.

    Download The Free Sample Report Here:

    https://www.thebusinessresearchcompany.com/sample.aspx?id=21102&type=smp

    Who are the Major Competitors in the Aortic Stenosis Market Outlook?

    Major companies operating in the aortic stenosis market are AstraZeneca plc, Abbott Laboratories, Medtronic plc, Boston Scientific Corporation, Terumo Corporation, Edwards Lifesciences Corporation, Biotronik SE & Co. KG, LivaNova PLC, Meril Life Sciences Pvt Ltd., Shockwave Medical Inc., Venus Medtech, Egnite Inc., JenaValve Technology Inc, Peijia Medical, Micro Interventional Devices Inc, CryoLife Inc., Coroneo Meril Life Sciences Pvt Ltd, Thubrikar Aortic Valve Inc., Anteris Technologies Ltd., Cardiawave

    What Is Fueling Growth in the Aortic Stenosis Market?

    The rise in heart disease cases is anticipated to stimulate the advancement of the aortic stenosis market. Heart diseases entail a spectrum of disorders impacting the heart’s structure and functionality. These disorders can interfere with the heart’s efficiency in pumping blood, resulting in complications. The most prevalent heart diseases include coronary artery disease (CAD), heart failure, arrhythmias, valvular heart disease, cardiomyopathy, among others. Aortic stenosis is a condition where the aortic valve becomes narrowed, obstructing blood flow from the left ventricle to the aorta. This obstruction leads to the heart exerting more effort, which in turn may result in heart failure and additional cardiovascular issues over time. Adequate treatment of aortic stenosis, like valve replacement or TAVI, aids in enhancing heart functionality and diminishes the risk of severe heart disease outcomes. For example, the British Heart Foundation reported in January 2025 that nearly 7.6 million people in the UK are faced with heart and circulatory diseases, including approximately 4 million males and 3.6 million females. These diseases are responsible for about 27% of all deaths in the UK, amounting to more than 170,000 deaths annually or 480 deaths each day. Hence, the escalating incidence of heart diseases is propelling the growth of the aortic stenosis market.

    Request For A Customized Report:

    https://www.thebusinessresearchcompany.com/customise?id=21102&type=smp

    Which Aortic Stenosis Market Segments Are Growing the Fastest?

    The aortic stenosis market covered in this report is segmented –

    1) By Type: Congenital Aortic Stenosis, Acquired Aortic Stenosis

    2) By Treatment: Surgical Aortic Valve Replacement, Transcatheter Aortic Valve Replacement, Balloon Aortic Valvuloplasty

    3) By Administration: Oral, Parenteral, Implants

    4) By Distribution Channel: Offline, Online

    5) By End User: Online Pharmacy, Retail Pharmacy, Hospital Pharmacy

    Subsegments:

    1) By Congenital Aortic Stenosis: Neonatal Aortic Stenosis, Infantile Aortic Stenosis, Juvenile Aortic Stenosis

    2) By Acquired Aortic Stenosis: Age-Related Aortic Stenosis, Degenerative Aortic Stenosis, Rheumatic Aortic Stenosis

    Which Industry Trends Are Shaping the Future of the Aortic Stenosis Market?

    In the aortic stenosis market, leading enterprises are concentratin on harnessing cutting-edge aortic valve techniques, including those relating to the use of transcatheter aortic valve implantation (TAVI) systems, with the goal to better patient outcomes, minimise associated procedure hazards, and increase the overall efficacy of aortic treatments. The TAVI system, an innovative medical device, facilitates the replacement of an affected aortic valve avoiding the need for open-heart operations. Abbott Laboratories, an American firm specializing in medical devices, for example, received the green light in January 2023 from the U.S. Food and Drug Administration (FDA) for Navitor, its latest TAVI system. Included in Navitor’s setup is a NaviSeal fabric cuff purposed to lower or eliminate paravalvular leaks. Additionally, the system design incorporating leaflets in the natural valve promotes more effective access for forthcoming coronary artery disease treatments.

    Access The Full Report Here:

    https://www.thebusinessresearchcompany.com/report/aortic-stenosis-global-market-report

    Which Countries Are Leading the Aortic Stenosis Market?

    North America was the largest region in the aortic stenosis market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the aortic stenosis market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

    Purchase The Full Report Today:

    https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=21102

    This Report Delivers Insight On:

    1. How big is the aortic stenosis market, and how is it changing globally?

    2. Who are the major companies in the aortic stenosis market, and how are they performing?

    3. What are the key opportunities and risks in the aortic stenosis market right now?

    4. Which products or customer segments are growing the most in the aortic stenosis market?

    5. What factors are helping or slowing down the growth of the aortic stenosis market?

    About The Business Research Company:

    With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

    Get in touch with us:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 310-496-7795

    Asia +44 2071930708

    Europe +44 7882 955267

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

  • Aortic Stenosis Market Trends 2025-2034: Growth, Strategic Insights, and Opportunities Ahead

    Aortic Stenosis Market Trends 2025-2034: Growth, Strategic Insights, and Opportunities Ahead

    Our market reports now include the latest updates on global tariffs, trade impacts, and evolving supply chain dynamics.

    What Are the Key Milestones in the Aortic Stenosis Market’s Growth Trajectory From 2025 To 2034?

    The sector of aortic stenosis has seen a swift expansion in its market size over the past few years. The growth is expected to rise from $7.88 billion in 2024 to $8.93 billion in 2025, with a compound annual growth rate (CAGR) of 13.3%. The increase during the historical period is due to multiple factors such as an aging population, a higher prevalence of risk-factors, advancements in diagnostic technologies, a heightened awareness of heart diseases and an improved healthcare infrastructure.

    In the next couple of years, a rapid expansion is anticipated in the aortic stenosis market, increasing its size to $14.54 billion by 2029, with a Compound Annual Growth Rate (CAGR) of 12.9%. This growth during the projected period could be because of the growing adoption of minimally invasive methods, an increased elderly population, hike in healthcare investments, improvements in access to healthcare in emerging markets, and enhancements in aortic valve replacement technologies. The upcoming trends for the forecast period are seen to be robotic-assisted surgery, 3D imaging and visualization, innovations in transcatheter aortic valve replacement (tavr), the usage of artificial intelligence in diagnostics, and the advent of biodegradable stents.

    Download a free sample to assess the report’s scope and structure:

    https://www.thebusinessresearchcompany.com/sample.aspx?id=21102&type=smp

    What Are the Major Market Drivers Behind the Rising Adoption of Aortic Stenosis Market?

    The rise in heart disease cases is predicted to fuel the expansion of the aortic stenosis market in the future. Conditions that impact the heart’s structure and functionality are collectively referred to as heart diseases. These health issues could have a detrimental effect on the heart’s blood pumping ability, causing repercussions. Common heart conditions include coronary artery disease (CAD), heart failure, arrhythmias, valvular heart diseases, cardiomyopathies, and others. Aortic stenosis, a condition characterized by a narrowed aortic valve, restricts blood flow from the left ventricle to the aorta. This resistance makes the heart exert more effort, potentially leading to heart failure and other cardiac complications over time. Effective aortic stenosis treatments like valve replacements or TAVIs can enhance heart functionality and lower the risk of major heart disease consequences. For example, in January 2025, the British Heart Foundation reported that nearly 7.6 million people in the UK, including approximately 4 million males and 3.6 million females, are living with heart and circulatory diseases. These health conditions contribute to roughly 27% of all UK deaths, causing over 170,000 deaths annually or about 480 daily deaths. Thus, the increasing occurrence of heart diseases is prompting the growth of the aortic stenosis market.

    Which Key Market Segments Comprise the Aortic Stenosis Market and Drive Its Revenue Growth?

    The aortic stenosis market covered in this report is segmented –

    1) By Type: Congenital Aortic Stenosis, Acquired Aortic Stenosis

    2) By Treatment: Surgical Aortic Valve Replacement, Transcatheter Aortic Valve Replacement, Balloon Aortic Valvuloplasty

    3) By Administration: Oral, Parenteral, Implants

    4) By Distribution Channel: Offline, Online

    5) By End User: Online Pharmacy, Retail Pharmacy, Hospital Pharmacy

    Subsegments:

    1) By Congenital Aortic Stenosis: Neonatal Aortic Stenosis, Infantile Aortic Stenosis, Juvenile Aortic Stenosis

    2) By Acquired Aortic Stenosis: Age-Related Aortic Stenosis, Degenerative Aortic Stenosis, Rheumatic Aortic Stenosis

    Request customized data on this market:

    https://www.thebusinessresearchcompany.com/customise?id=21102&type=smp

    Which Areas Are Leading Regions in the Aortic Stenosis Market Expansion Across the Globe?

    North America was the largest region in the aortic stenosis market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the aortic stenosis market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

    What Are the Strategic Trends Steering theAortic Stenosis Market Direction?

    Leading firms in the aortic stenosis market are concentrating on the creation of innovative aortic valve technologies such as the Transcatheter Aortic Valve Implantation (TAVI) systems. These are aimed at enhancing patient results, mitigating procedural dangers, and maximizing overall treatment efficacy for aortic conditions. The TAVI system, a minimally invasive medical device, enables the replacement of a malfunctioning aortic valve without resorting to open-heart surgery. For instance, Abbott Laboratories, a medical device firm based in the US, obtained approval for Navitor, its newest generation TAVI system, from the U.S. Food and Drug Administration (FDA) in January 2023. The Navitor system utilizes the NaviSeal fabric cuff to decrease or eradicate paravalvular leaks. Its design, that includes leaflets within the original valve, is devised to enhance accessibility to coronary arteries for subsequent treatments of coronary artery disease.

    View the full report here:

    https://www.thebusinessresearchcompany.com/report/aortic-stenosis-global-market-report

    How Is the Aortic Stenosis Market Conceptually Defined?

    Aortic stenosis is a condition where the aortic valve in the heart becomes narrowed, restricting blood flow from the left ventricle to the aorta and the rest of the body. It is often caused by age-relate valve calcification, congenital valve defects, or rheumatic fever. Aortic stenosis can lead to serious complications such as heart failure, which can be treated with medication or surgical interventions such as valve replacement.

    Purchase the full report and get a swift delivery:

    https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=21102

    About The Business Research Company:

    With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

    Get in touch with us:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 3156230293

    Asia +44 2071930708

    Europe +44 2071930708

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

  • Aortic Stenosis Market Trends 2025-2034: Growth, Strategic Insights, and Opportunities Ahead

    Aortic Stenosis Market Trends 2025-2034: Growth, Strategic Insights, and Opportunities Ahead

    2025 Market Reports Update: Market Size Forecasts to 2034, Key Trends, Leading Players, and Top Regions – Get Ahead of the Competition Today!

    Which Primary Drivers Are Supporting the Continued Market Growth of theAortic Stenosis Market?

    The rising number of heart disease cases is expected to drive the growth of the aortic stenosis market moving forward. Heart diseases refer to a variety of conditions that affect the structure and function of the heart, which can interfere with its ability to pump blood effectively, leading to various complications. Common heart conditions include coronary artery disease (CAD), heart failure, arrhythmias, valvular heart disease, cardiomyopathy, and more. Aortic stenosis is a condition in which the aortic valve narrows, restricting blood flow from the left ventricle to the aorta. This resistance forces the heart to exert more effort, which can lead to heart failure and other cardiovascular issues over time. Treating aortic stenosis with procedures like valve replacement or TAVI can improve heart function and reduce severe heart disease risks. For instance, in January 2025, the British Heart Foundation, a UK-based cardiovascular research charity, reported that approximately 7.6 million people in the UK suffer from heart and circulatory diseases, including about 4 million men and 3.6 million women. These conditions are responsible for approximately 27% of all deaths in the UK, leading to over 170,000 fatalities annually, which is about 480 deaths per day. Therefore, the increasing prevalence of heart diseases is contributing to the growth of the aortic stenosis market.

    Get Your Free Sample Report Now – Explore Exclusive Market Insights:

    https://www.thebusinessresearchcompany.com/sample.aspx?id=21102&type=smp

    #How Will the CAGR of the Aortic Stenosis Market Influence Its Overall Growth by 2034?

    The aortic stenosis market has expanded rapidly. It is projected to grow from $7.88 billion in 2024 to $8.93 billion in 2025 at a CAGR of 13.3%. Contributing factors to past growth include an aging population, a rising prevalence of risk factors, advancements in diagnostic tools, heightened awareness of heart conditions, and improvements in healthcare infrastructure.

    The aortic stenosis market size is projected to experience significant expansion over the next few years, reaching $14.54 billion by 2029 with a compound annual growth rate (CAGR) of 12.9%. This growth will be driven by the increasing adoption of minimally invasive procedures, a growing elderly population, rising healthcare expenditures, enhanced access to healthcare in emerging regions, and advancements in aortic valve replacement technology. Key trends expected during this period include robotic-assisted surgeries, 3D imaging and visualization, innovations in transcatheter aortic valve replacement (TAVR), artificial intelligence in diagnostics, and biodegradable stents.

    You can Directly Purchase the Report Here:

    https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=21102

    How Are Consumer Market Innovations Shaping the Current and Future Landscape of theAortic Stenosis Market?

    In the aortic stenosis market, companies are focusing on developing innovative aortic valve technologies, such as transcatheter aortic valve implantation (TAVI) systems, to improve patient outcomes, reduce procedural risks, and increase the overall effectiveness of treatment. The TAVI system is a minimally invasive device that can replace a diseased aortic valve without open-heart surgery. For example, in January 2023, Abbott Laboratories, a U.S.-based medical device company, received FDA approval for Navitor, a latest-generation TAVI system. Navitor features the NaviSeal fabric cuff to reduce or eliminate paravalvular leaks. Its design, with leaflets within the native valve, improves access to coronary arteries for future coronary artery disease treatments.

    Who Are the Key Market Players Influencing the Growth of the Corn and Aortic Stenosis Industry?

    Major companies operating in the aortic stenosis market are AstraZeneca plc, Abbott Laboratories, Medtronic plc, Boston Scientific Corporation, Terumo Corporation, Edwards Lifesciences Corporation, Biotronik SE & Co. KG, LivaNova PLC, Meril Life Sciences Pvt Ltd., Shockwave Medical Inc., Venus Medtech, Egnite Inc., JenaValve Technology Inc, Peijia Medical, Micro Interventional Devices Inc, CryoLife Inc., Coroneo Meril Life Sciences Pvt Ltd, Thubrikar Aortic Valve Inc., Anteris Technologies Ltd., Cardiawave

    Order Your Report Now For A Swift Delivery:

    https://www.thebusinessresearchcompany.com/report/aortic-stenosis-global-market-report

    Which Key Market Segments Comprise the Aortic Stenosis Market and Drive Its Revenue Growth?

    The aortic stenosis market covered in this report is segmented –

    1) By Type: Congenital Aortic Stenosis, Acquired Aortic Stenosis

    2) By Treatment: Surgical Aortic Valve Replacement, Transcatheter Aortic Valve Replacement, Balloon Aortic Valvuloplasty

    3) By Administration: Oral, Parenteral, Implants

    4) By Distribution Channel: Offline, Online

    5) By End User: Online Pharmacy, Retail Pharmacy, Hospital Pharmacy

    Subsegments:

    1) By Congenital Aortic Stenosis: Neonatal Aortic Stenosis, Infantile Aortic Stenosis, Juvenile Aortic Stenosis

    2) By Acquired Aortic Stenosis: Age-Related Aortic Stenosis, Degenerative Aortic Stenosis, Rheumatic Aortic Stenosis

    Gain Exclusive Market Insights—Customize Your Research Report Today for Fast Delivery!

    https://www.thebusinessresearchcompany.com/customise?id=21102&type=smp

    Which Regions Are Emerging as Leaders in the Aortic Stenosis Market?

    North America was the largest region in the aortic stenosis market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the aortic stenosis market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

    Browse Through More Reports Similar to the Global Aortic Stenosis Market 2025, By The Business Research Company:

    Chronic Pain Global Market Report 2025

    https://www.thebusinessresearchcompany.com/report/chronic-pain-global-market-report

    Late Stage Chronic Kidney Disease Drugs Global Market Report 2025

    https://www.thebusinessresearchcompany.com/report/late-stage-chronic-kidney-disease-drugs-global-market-report

    Chronic Lymphocytic Leukemia Treatment Global Market Report 2025

    https://thebusinessresearchcompany.com/report/chronic-lymphocytic-leukemia-treatment-global-market-report

    About The Business Research Company:

    With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

    Contact us at:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 3156230293

    Asia +44 2071930708

    Europe +44 2071930708

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

    Found this article helpful? Share it on:

  • In-Depth Insights into the Aortic Stenosis Market: Growth, Trends, and Opportunities for 2025-2034

    In-Depth Insights into the Aortic Stenosis Market: Growth, Trends, and Opportunities for 2025-2034

    Get 20% off on Global Market Reports until March 31st! Use code FY25SAVE at checkout.

    What key factors are powering the surge in the aortic stenosis market right now?

    The market size for aortic stenosis has seen a swift expansion in the past few years. It is projected to surge from $7.88 billion in 2024 to $8.93 billion in 2025, displaying a compound annual growth rate (CAGR) of 13.3%. The market’s growth during the historic term is credited to several factors such as the aging population, heightened occurrence of risk factors, advancements in diagnostic tech, rising awareness about heart diseases, and improved healthcare infrastructure.

    How fast Is the aortic stenosis market expected to grow, and what’s its future value?

    The size of the aortic stenosis market is predicted to experience brisk expansion in the coming years. It is projected to escalate to $14.54 billion by 2029 with a Compound Annual Growth Rate (CAGR) of 12.9%. Factors contributing to the expected growth during the projected period include the increasing adoption of less invasive procedures, a growing elderly population, a rise in healthcare spending, expansion in healthcare access in emerging markets, and technological advancements in aortic valve replacements. Key trends anticipated during the forecast period encompass robotic-assisted surgery, 3d imaging and visualization, innovations in transcatheter aortic valve replacement (TAVR), the use of artificial intelligence in diagnostics, and biodegradable stents.

    Get your aortic stenosis market report here!

    https://www.thebusinessresearchcompany.com/report/aortic-stenosis-global-market-report

    What are the leading drivers of growth in the aortic stenosis market?

    The rise in instances of cardiovascular conditions is anticipated to boost the aortic stenosis market’s trajectory. These conditions, collectively referred to as heart diseases, encompass a variety of issues that affect the heart’s anatomy and functionality. They can inhibit the heart’s effectiveness in pumping blood, leading to further complications. Diseases like coronary artery disease (CAD), heart failure, arrhythmias, valvular heart disease, cardiomyopathy, and others are common types. Aortic stenosis focuses on the constriction of the aortic valve, restricting blood flow from the left ventricle to the aorta. The result of this increased resistance is additional strain on the heart, which could evolve into heart failure or other cardiovascular issues over time. Correct management of aortic stenosis through valve replacement or TAVI can enhance heart performance and diminish the likelihood of severe outcomes from heart diseases. By way of example, the British Heart Foundation reported in January 2025 that approximately 7.6 million people in the UK—4 million men and 3.6 million women—are dealing with heart and circulatory diseases. These conditions represent around 27% of every fatality in the UK, contributing to over 170,000 deaths yearly or roughly 480 deaths daily. As a result, the escalating prevalence of heart diseases stimulates the expansion of the aortic stenosis market.

    What are the key segments defining the aortic stenosis market?

    The aortic stenosis market covered in this report is segmented –

    1) By Type: Congenital Aortic Stenosis, Acquired Aortic Stenosis

    2) By Treatment: Surgical Aortic Valve Replacement, Transcatheter Aortic Valve Replacement, Balloon Aortic Valvuloplasty

    3) By Administration: Oral, Parenteral, Implants

    4) By Distribution Channel: Offline, Online

    5) By End User: Online Pharmacy, Retail Pharmacy, Hospital Pharmacy

    Subsegments:

    1) By Congenital Aortic Stenosis: Neonatal Aortic Stenosis, Infantile Aortic Stenosis, Juvenile Aortic Stenosis

    2) By Acquired Aortic Stenosis: Age-Related Aortic Stenosis, Degenerative Aortic Stenosis, Rheumatic Aortic Stenosis

    Get your free sample now – explore exclusive market insights:

    https://www.thebusinessresearchcompany.com/sample.aspx?id=21102&type=smp

    Who are the key players steering the development of the aortic stenosis market?

    Major companies operating in the aortic stenosis market are AstraZeneca plc, Abbott Laboratories, Medtronic plc, Boston Scientific Corporation, Terumo Corporation, Edwards Lifesciences Corporation, Biotronik SE & Co. KG, LivaNova PLC, Meril Life Sciences Pvt Ltd., Shockwave Medical Inc., Venus Medtech, Egnite Inc., JenaValve Technology Inc, Peijia Medical, Micro Interventional Devices Inc, CryoLife Inc., Coroneo Meril Life Sciences Pvt Ltd, Thubrikar Aortic Valve Inc., Anteris Technologies Ltd., Cardiawave

    What emerging trends are influencing the growth of the aortic stenosis market?

    Major firms in the aortic stenosis market are concentrating on the production of breakthrough aortic valve technologies such as transcatheter aortic valve implantation (TAVI) systems. Their goal is to enhance patient outcomes, minimize the risks associated with procedures, and boost the effectiveness of aortic treatments overall. The Transcatheter Aortic Valve Implantation (TAVI) system, a less invasive medical device, can substitute a damaged aortic valve without the need for open-heart surgery. For instance, in January 2023, Abbott Laboratories, a medical device company based in the US, obtained permission for Navitor, their latest generation transcatheter aortic valve implantation (TAVI) system, from the U.S. Food and Drug Administration (FDA). Navitor includes the NaviSeal fabric cuff to diminish or totally eradicate paravalvular leakages. The design of the system, featuring leaflets within the native valve, is intended to enhance access to coronary arteries for potential coronary artery disease treatments.

    Unlock exclusive market insights – purchase your research report now for a swift delivery!

    https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=21102

    Which regions are most influential in expanding the aortic stenosis market?

    North America was the largest region in the aortic stenosis market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the aortic stenosis market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

    Browse Through More Similar Reports By The Business Research Company:

    Chronic Pain Global Market Report 2025

    https://www.thebusinessresearchcompany.com/report/chronic-pain-global-market-report

    Late Stage Chronic Kidney Disease Drugs Global Market Report 2025

    https://www.thebusinessresearchcompany.com/report/late-stage-chronic-kidney-disease-drugs-global-market-report

    Chronic Lymphocytic Leukemia Treatment Global Market Report 2025

    https://thebusinessresearchcompany.com/report/chronic-lymphocytic-leukemia-treatment-global-market-report

    About The Business Research Company:

    With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

    Contact us at:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 3156230293

    Asia +44 2071930708

    Europe +44 2071930708

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

    Found this article helpful? Share it on:

  • Aortic Stenosis Growth Forecast 2025-2034: Trends, Opportunities, and Key Insights You Need to Know

    Aortic Stenosis Growth Forecast 2025-2034: Trends, Opportunities, and Key Insights You Need to Know

    Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!

    What is the Predicted CAGR for the Aortic Stenosis Market Over the Forecast Period of 2025 to 2034?

    The market size for aortic stenosis has seen swift expansion in the past years. There’s a prediction for growth from $7.88 billion in 2024 to an estimated $8.93 billion in 2025, reflecting a compound annual growth rate (CAGR) of 13.3%. This expansion during the historic phase can be linked to elements such as the aging demographic, heightened prevalence of associated risk factors, advancements in diagnostic technology, rising recognition of cardiac diseases, and enhanced healthcare infrastructure.

    The size of the aortic stenosis market is projected to experience accelerated growth in the forthcoming years. It is set to expand to $14.54 billion by 2029, with a compound annual growth rate (CAGR) of 12.9%. The rise in the forecast period can be credited to an increased uptake of minimally invasive procedures, the growth of the elderly population, expanding healthcare spending, improved access to healthcare in emergent markets, and advancements in aortic valve replacement technology. Significant trends anticipated in the forecast period embrace robotic-assisted surgeries, 3D imaging and visualization, innovative developments in transcatheter aortic valve replacement (tavr), the application of artificial intelligence in diagnostics, and the use of biodegradable stents.

    What Major Innovations Are Driving the Accelerated Growth of the Aortic Stenosis Market?

    The rise in heart disease is projected to fuel the expansion of the aortic stenosis market in the future. Heart diseases are a broad set of conditions impacting the heart’s structure and functionality. These diseases can hinder the heart’s capacity to efficiently pump blood, causing complications. Some familiar heart diseases are coronary artery disease (CAD), heart failure, arrhythmias, valvular heart disease, cardiomyopathy and others. Aortic stenosis pertains to the constriction of the aortic valve, impeding the blood flow from the left ventricle to the aorta. This heightens the resistance for the heart, obligating it to work harder and risking potential heart failure and cardiovascular complications over time. Appropriate interventions for aortic stenosis, such as valve replacement or TAVI, can enhance heart performance and lower the risk of severe heart disease consequences. According to the British Heart Foundation, a UK-based charity focused on cardiovascular research, it is projected that by January 2025, there will be about 7.6 million people in the UK suffering from heart and circulatory diseases, including roughly 4 million men and 3.6 million women. These diseases are responsible for approximately 27% of all the deaths in the UK, resulting in over 170,000 deaths annually or about 480 deaths every day. Therefore, the escalating incidences of heart diseases are contributing to the growth of the aortic stenosis market.

    Request Your Free Aortic Stenosis Market Report Sample Now!

    https://www.thebusinessresearchcompany.com/sample.aspx?id=21102&type=smp

    Who are the key firms paving the way for growth in the Aortic Stenosis market?

    Major companies operating in the aortic stenosis market are AstraZeneca plc, Abbott Laboratories, Medtronic plc, Boston Scientific Corporation, Terumo Corporation, Edwards Lifesciences Corporation, Biotronik SE & Co. KG, LivaNova PLC, Meril Life Sciences Pvt Ltd., Shockwave Medical Inc., Venus Medtech, Egnite Inc., JenaValve Technology Inc, Peijia Medical, Micro Interventional Devices Inc, CryoLife Inc., Coroneo Meril Life Sciences Pvt Ltd, Thubrikar Aortic Valve Inc., Anteris Technologies Ltd., Cardiawave

    What Key Trends Are Currently Impacting the Aortic Stenosis Market’s Development?

    Leading businesses in the aortic stenosis industry are concentrating their efforts on the creation of cutting-edge aortic valve technologies like the transcatheter aortic valve implantation (TAVI) systems. These innovations are aimed at enhancing patient results, diminishing the dangers tied to the procedure, and upgrading the overall efficacy of the aortic treatment. The TAVI system, which is a less invasive substitute to open-heart surgery, can replace an ailing aortic valve. For example, in January 2023, the FDA gave approval to Abbott Laboratories, an American medical device firm, for their newest TAVI system called Navitor. This system uses the NaviSeal fabric cuff to decrease or even avoid paravalvular leaks. Additionally, the system is designed to place leaflets within the native valve, with the goal of enhancing access to coronary arteries for future treatments of coronary artery disease.

    Pre-order Your Report for Quick and Easy Delivery!

    https://www.thebusinessresearchcompany.com/report/aortic-stenosis-global-market-report

    Which Segments Play a Crucial Role in the Expansion of the Aortic Stenosis Market?

    The aortic stenosis market covered in this report is segmented –

    1) By Type: Congenital Aortic Stenosis, Acquired Aortic Stenosis

    2) By Treatment: Surgical Aortic Valve Replacement, Transcatheter Aortic Valve Replacement, Balloon Aortic Valvuloplasty

    3) By Administration: Oral, Parenteral, Implants

    4) By Distribution Channel: Offline, Online

    5) By End User: Online Pharmacy, Retail Pharmacy, Hospital Pharmacy

    Subsegments:

    1) By Congenital Aortic Stenosis: Neonatal Aortic Stenosis, Infantile Aortic Stenosis, Juvenile Aortic Stenosis

    2) By Acquired Aortic Stenosis: Age-Related Aortic Stenosis, Degenerative Aortic Stenosis, Rheumatic Aortic Stenosis

    Which Geographical Regions Are Pioneering Growth in the Aortic Stenosis Market?

    North America was the largest region in the aortic stenosis market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the aortic stenosis market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

    How Do Experts Define the Scope of the Aortic Stenosis Market?

    Aortic stenosis is a condition where the aortic valve in the heart becomes narrowed, restricting blood flow from the left ventricle to the aorta and the rest of the body. It is often caused by age-relate valve calcification, congenital valve defects, or rheumatic fever. Aortic stenosis can lead to serious complications such as heart failure, which can be treated with medication or surgical interventions such as valve replacement.

    Browse Through More Similar Reports By The Business Research Company:

    Chronic Pain Global Market Report 2025

    https://www.thebusinessresearchcompany.com/report/chronic-pain-global-market-report

    Late Stage Chronic Kidney Disease Drugs Global Market Report 2025

    https://www.thebusinessresearchcompany.com/report/late-stage-chronic-kidney-disease-drugs-global-market-report

    Chronic Lymphocytic Leukemia Treatment Global Market Report 2025

    https://thebusinessresearchcompany.com/report/chronic-lymphocytic-leukemia-treatment-global-market-report

    About The Business Research Company:

    With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

    Contact us at:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 3156230293

    Asia +44 2071930708

    Europe +44 2071930708

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

    Found this article helpful? Share it on: